Literature DB >> 8060153

Epidermolysis bullosa herpetiformis (Dowling-Meara type) exhibits ultrastructural derangement of tonofilaments and desmosomes.

M Furumura1, S Imayama, Y Hori.   

Abstract

Ultrastructural and immunohistochemical studies of clinically intact skin obtained from three severe neonatal cases of epidermolysis bullosa herpetiformis (Dowling-Meara type) demonstrated disorders in the assembly of keratin intermediate filaments and desmosomes of the keratinocytes. During mitosis, K5- and K14-positive and K1- and K10-negative tonofilaments were disrupted and formed spherical bodies associated with intracytoplasmic desmosomes by invagination of the desmosomes and the adjacent plasma membrane. During the invagination process, destructive changes in the internalized membrane were noted. These were accompanied by gradual loss of reactivity with a monoclonal antibody ZK31, which detected plasma membrane adjacent to the attachment plaques of desmosomes. However, the reactivity of the attachment plaques of the internalized desmosomes for desmoplakins and desmoglein did not decline during the process of internalization. In the suprabasal layers of the epidermis, filamentous substructures and K1 and K10 appeared at the periphery of the spherical bodies. Simultaneously, the desmosomes that were sparsely located in the lower epidermis, increased in number as cell differentiation progressed. Thus, the keratinocytes attained an almost normal appearance with respect to tonofilaments and desmosomes by the time they reached the upper layer of the epidermis. These findings may be relevant to the mechanism responsible for the clinical appearance of the herpetiform blisters in epidermolysis bullosa herpetiformis, which are also characterized by spontaneous involution during childhood or when exposed to high ambient temperatures.

Entities:  

Mesh:

Year:  1994        PMID: 8060153     DOI: 10.1007/bf00387594

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  41 in total

1.  The effect of age on mitosis in the human epidermis.

Authors:  J M THURINGER; A A KATZBERG
Journal:  J Invest Dermatol       Date:  1959-08       Impact factor: 8.551

2.  Epidermolysis bullosa resembling juvenile dermatitis herpetiformis.

Authors:  G B DOWLING; R H MEARA
Journal:  Br J Dermatol       Date:  1954-04       Impact factor: 9.302

3.  Desmosome-like structures in the cytoplasm of normal human keratinocyte.

Authors:  J Komura; S Watanabe
Journal:  Arch Dermatol Res       Date:  1975-09-12       Impact factor: 3.017

4.  [Desmosomal structures in the cytoplasm of normal and abnormal keratinocytes (author's transl)].

Authors:  P Schenk
Journal:  Arch Dermatol Res       Date:  1975-08-29       Impact factor: 3.017

Review 5.  Immuno- and affinity probes for electron microscopy: a review of labeling and preparation techniques.

Authors:  J W Stirling
Journal:  J Histochem Cytochem       Date:  1990-02       Impact factor: 2.479

Review 6.  Epidermolysis bullosa: a review.

Authors:  T W Cooper; E A Bauer
Journal:  Pediatr Dermatol       Date:  1984-01       Impact factor: 1.588

7.  A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering.

Authors:  E B Lane; E L Rugg; H Navsaria; I M Leigh; A H Heagerty; A Ishida-Yamamoto; R A Eady
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

8.  Severe infantile epidermolysis bullosa simplex. Dowling-Meara type.

Authors:  L H Buchbinder; A W Lucky; E Ballard; J R Stanley; E Stolar; M Tabas; E A Bauer; A S Paller
Journal:  Arch Dermatol       Date:  1986-02

9.  The complement of desmosomal plaque proteins in different cell types.

Authors:  P Cowin; H P Kapprell; W W Franke
Journal:  J Cell Biol       Date:  1985-10       Impact factor: 10.539

10.  Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies.

Authors:  A M Gown; A M Vogel
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.